Early tox material can offer valuable clarity as programs progress toward IND. Lonza's latest white paper introduces a new offering that helps drug developers shorten timelines and generate tox material in as little as 2.5 months.

Inside, you will find insights on:

• Strategies from this new approach that accelerate IND readiness through early tox material supply
• How early material supply accelerates development
• Process and formulation strategies that support even high concentration molecules
• Technologies that improve pairing, purity and stability

Brought to you by